Home

Andrew Obenshain

CIK 1839697 · President and CEO · last filed 2025-06-03

Andrew Obenshain is a President and CEO who has filed 33 SEC Form 4 insider transactions across 1 company since 2021. The most recent filing, for BLUE, was dated Jun 3, 2025. Across all open-market trades the lifetime net is −$354.1K, making them a net seller over the disclosed history. 34 SEC filings were submitted jointly with bluebird bio, Inc.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

1

Total Filings

33

Lifetime Open-Market Net

-$354.1K

Filer Profile

Reported Address
C/O BLUEBIRD BIO, INC.
455 GRAND UNION BOULEVARD
SOMERVILLE, MA 02145
Related Filers
bluebird bio, Inc. — 34 joint filings, latest 2025-06-03
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
bluebird bio, Inc. (BLUE) Delisted President and CEO 9,300 $4.97 $46.2K -$354.1K 28 2025-06-03

Recent Filings

33 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2025-06-03 bluebird bio, Inc. (BLUE) Delisted Mixed −18,327 $0 EDGAR
2025-03-05 bluebird bio, Inc. (BLUE) Delisted Sell (S) −921 -$3.6K EDGAR
2025-03-03 bluebird bio, Inc. (BLUE) Delisted Notice (144) −921 -$3.6K EDGAR
2025-02-12 bluebird bio, Inc. (BLUE) Delisted Grant (A) +763 $0 EDGAR
2025-02-05 bluebird bio, Inc. (BLUE) Delisted Sell (S) −86 -$636 EDGAR
2025-02-03 bluebird bio, Inc. (BLUE) Delisted Notice (144) −86 -$665 EDGAR
2025-01-08 bluebird bio, Inc. (BLUE) Delisted Sell (S) −140 -$1.3K EDGAR
2025-01-06 bluebird bio, Inc. (BLUE) Delisted Notice (144) −140 -$1.2K EDGAR
2024-12-12 bluebird bio, Inc. (BLUE) Delisted Sell (S) −971 -$405 EDGAR
2024-12-10 bluebird bio, Inc. (BLUE) Delisted Notice (144) −971 -$437 EDGAR
Showing 1–10 of 33
Page 1 of 4
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.